[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 RNA Vaccine Market - Global Outlook and Forecast 2021-2027

April 2021 | 93 pages | ID: CCF77643E4C7EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of COVID-19 RNA Vaccine in Global, including the following market information:

Global COVID-19 RNA Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global COVID-19 RNA Vaccine market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the COVID-19 RNA Vaccine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global COVID-19 RNA Vaccine Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global COVID-19 RNA Vaccine Market Segment Percentages, By Type, 2020 (%)
  • Being Developed
  • Preclinical
  • Clinical I
  • Clinical II
China COVID-19 RNA Vaccine Market, By Application, 2016-2021, 2022-2027 ($ millions)

China COVID-19 RNA Vaccine Market Segment Percentages, By Application, 2020 (%)
  • Pharmaceutical And Biotechnology Companies
  • Hospital
  • Academic And Research Organizations
  • Other
Global COVID-19 RNA Vaccine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global COVID-19 RNA Vaccine Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total COVID-19 RNA Vaccine Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total COVID-19 RNA Vaccine Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • MODERNA
  • CureVac
  • Zydus Cadila
  • BioNTech
  • Stermirna
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 COVID-19 RNA Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global COVID-19 RNA Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COVID-19 RNA VACCINE OVERALL MARKET SIZE

2.1 Global COVID-19 RNA Vaccine Market Size: 2021 VS 2027
2.2 Global COVID-19 RNA Vaccine Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top COVID-19 RNA Vaccine Players in Global Market
3.2 Top Global COVID-19 RNA Vaccine Companies Ranked by Revenue
3.3 Global COVID-19 RNA Vaccine Revenue by Companies
3.4 Top 3 and Top 5 COVID-19 RNA Vaccine Companies in Global Market, by Revenue in 2020
3.5 Global Companies COVID-19 RNA Vaccine Product Type
3.6 Tier 1, Tier 2 and Tier 3 COVID-19 RNA Vaccine Players in Global Market
  3.6.1 List of Global Tier 1 COVID-19 RNA Vaccine Companies
  3.6.2 List of Global Tier 2 and Tier 3 COVID-19 RNA Vaccine Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global COVID-19 RNA Vaccine Market Size Markets, 2021 & 2027
  4.1.2 Being Developed
  4.1.3 Preclinical
  4.1.4 Clinical I
  4.1.5 Clinical II
4.2 By Type - Global COVID-19 RNA Vaccine Revenue & Forecasts
  4.2.1 By Type - Global COVID-19 RNA Vaccine Revenue, 2016-2021
  4.2.2 By Type - Global COVID-19 RNA Vaccine Revenue, 2022-2027
  4.2.3 By Type - Global COVID-19 RNA Vaccine Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global COVID-19 RNA Vaccine Market Size, 2021 & 2027
  5.1.2 Pharmaceutical And Biotechnology Companies
  5.1.3 Hospital
  5.1.4 Academic And Research Organizations
  5.1.5 Other
5.2 By Application - Global COVID-19 RNA Vaccine Revenue & Forecasts
  5.2.1 By Application - Global COVID-19 RNA Vaccine Revenue, 2016-2021
  5.2.2 By Application - Global COVID-19 RNA Vaccine Revenue, 2022-2027
  5.2.3 By Application - Global COVID-19 RNA Vaccine Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global COVID-19 RNA Vaccine Market Size, 2021 & 2027
6.2 By Region - Global COVID-19 RNA Vaccine Revenue & Forecasts
  6.2.1 By Region - Global COVID-19 RNA Vaccine Revenue, 2016-2021
  6.2.2 By Region - Global COVID-19 RNA Vaccine Revenue, 2022-2027
  6.2.3 By Region - Global COVID-19 RNA Vaccine Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America COVID-19 RNA Vaccine Revenue, 2016-2027
  6.3.2 US COVID-19 RNA Vaccine Market Size, 2016-2027
  6.3.3 Canada COVID-19 RNA Vaccine Market Size, 2016-2027
  6.3.4 Mexico COVID-19 RNA Vaccine Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe COVID-19 RNA Vaccine Revenue, 2016-2027
  6.4.2 Germany COVID-19 RNA Vaccine Market Size, 2016-2027
  6.4.3 France COVID-19 RNA Vaccine Market Size, 2016-2027
  6.4.4 U.K. COVID-19 RNA Vaccine Market Size, 2016-2027
  6.4.5 Italy COVID-19 RNA Vaccine Market Size, 2016-2027
  6.4.6 Russia COVID-19 RNA Vaccine Market Size, 2016-2027
  6.4.7 Nordic Countries COVID-19 RNA Vaccine Market Size, 2016-2027
  6.4.8 Benelux COVID-19 RNA Vaccine Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia COVID-19 RNA Vaccine Revenue, 2016-2027
  6.5.2 China COVID-19 RNA Vaccine Market Size, 2016-2027
  6.5.3 Japan COVID-19 RNA Vaccine Market Size, 2016-2027
  6.5.4 South Korea COVID-19 RNA Vaccine Market Size, 2016-2027
  6.5.5 Southeast Asia COVID-19 RNA Vaccine Market Size, 2016-2027
  6.5.6 India COVID-19 RNA Vaccine Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America COVID-19 RNA Vaccine Revenue, 2016-2027
  6.6.2 Brazil COVID-19 RNA Vaccine Market Size, 2016-2027
  6.6.3 Argentina COVID-19 RNA Vaccine Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa COVID-19 RNA Vaccine Revenue, 2016-2027
  6.7.2 Turkey COVID-19 RNA Vaccine Market Size, 2016-2027
  6.7.3 Israel COVID-19 RNA Vaccine Market Size, 2016-2027
  6.7.4 Saudi Arabia COVID-19 RNA Vaccine Market Size, 2016-2027
  6.7.5 UAE COVID-19 RNA Vaccine Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 MODERNA
  7.1.1 MODERNA Corporate Summary
  7.1.2 MODERNA Business Overview
  7.1.3 MODERNA COVID-19 RNA Vaccine Major Product Offerings
  7.1.4 MODERNA COVID-19 RNA Vaccine Revenue in Global (2016-2021)
  7.1.5 MODERNA Key News
7.2 CureVac
  7.2.1 CureVac Corporate Summary
  7.2.2 CureVac Business Overview
  7.2.3 CureVac COVID-19 RNA Vaccine Major Product Offerings
  7.2.4 CureVac COVID-19 RNA Vaccine Revenue in Global (2016-2021)
  7.2.5 CureVac Key News
7.3 Zydus Cadila
  7.3.1 Zydus Cadila Corporate Summary
  7.3.2 Zydus Cadila Business Overview
  7.3.3 Zydus Cadila COVID-19 RNA Vaccine Major Product Offerings
  7.3.4 Zydus Cadila COVID-19 RNA Vaccine Revenue in Global (2016-2021)
  7.3.5 Zydus Cadila Key News
7.4 BioNTech
  7.4.1 BioNTech Corporate Summary
  7.4.2 BioNTech Business Overview
  7.4.3 BioNTech COVID-19 RNA Vaccine Major Product Offerings
  7.4.4 BioNTech COVID-19 RNA Vaccine Revenue in Global (2016-2021)
  7.4.5 BioNTech Key News
7.5 Stermirna
  7.5.1 Stermirna Corporate Summary
  7.5.2 Stermirna Business Overview
  7.5.3 Stermirna COVID-19 RNA Vaccine Major Product Offerings
  7.5.4 Stermirna COVID-19 RNA Vaccine Revenue in Global (2016-2021)
  7.5.5 Stermirna Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. COVID-19 RNA Vaccine Market Opportunities & Trends in Global Market
Table 2. COVID-19 RNA Vaccine Market Drivers in Global Market
Table 3. COVID-19 RNA Vaccine Market Restraints in Global Market
Table 4. Key Players of COVID-19 RNA Vaccine in Global Market
Table 5. Top COVID-19 RNA Vaccine Players in Global Market, Ranking by Revenue (2019)
Table 6. Global COVID-19 RNA Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global COVID-19 RNA Vaccine Revenue Share by Companies, 2016-2021
Table 8. Global Companies COVID-19 RNA Vaccine Product Type
Table 9. List of Global Tier 1 COVID-19 RNA Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 COVID-19 RNA Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global COVID-19 RNA Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - COVID-19 RNA Vaccine Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - COVID-19 RNA Vaccine Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global COVID-19 RNA Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - COVID-19 RNA Vaccine Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - COVID-19 RNA Vaccine Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global COVID-19 RNA Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global COVID-19 RNA Vaccine Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global COVID-19 RNA Vaccine Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America COVID-19 RNA Vaccine Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe COVID-19 RNA Vaccine Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia COVID-19 RNA Vaccine Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America COVID-19 RNA Vaccine Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa COVID-19 RNA Vaccine Revenue, (US$, Mn), 2022-2027
Table 30. MODERNA Corporate Summary
Table 31. MODERNA COVID-19 RNA Vaccine Product Offerings
Table 32. MODERNA COVID-19 RNA Vaccine Revenue (US$, Mn), (2016-2021)
Table 33. CureVac Corporate Summary
Table 34. CureVac COVID-19 RNA Vaccine Product Offerings
Table 35. CureVac COVID-19 RNA Vaccine Revenue (US$, Mn), (2016-2021)
Table 36. Zydus Cadila Corporate Summary
Table 37. Zydus Cadila COVID-19 RNA Vaccine Product Offerings
Table 38. Zydus Cadila COVID-19 RNA Vaccine Revenue (US$, Mn), (2016-2021)
Table 39. BioNTech Corporate Summary
Table 40. BioNTech COVID-19 RNA Vaccine Product Offerings
Table 41. BioNTech COVID-19 RNA Vaccine Revenue (US$, Mn), (2016-2021)
Table 42. Stermirna Corporate Summary
Table 43. Stermirna COVID-19 RNA Vaccine Product Offerings
Table 44. Stermirna COVID-19 RNA Vaccine Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. COVID-19 RNA Vaccine Segment by Type
Figure 2. COVID-19 RNA Vaccine Segment by Application
Figure 3. Global COVID-19 RNA Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global COVID-19 RNA Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global COVID-19 RNA Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by COVID-19 RNA Vaccine Revenue in 2020
Figure 8. By Type - Global COVID-19 RNA Vaccine Revenue Market Share, 2016-2027
Figure 9. By Application - Global COVID-19 RNA Vaccine Revenue Market Share, 2016-2027
Figure 10. By Region - Global COVID-19 RNA Vaccine Revenue Market Share, 2016-2027
Figure 11. By Country - North America COVID-19 RNA Vaccine Revenue Market Share, 2016-2027
Figure 12. US COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 13. Canada COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe COVID-19 RNA Vaccine Revenue Market Share, 2016-2027
Figure 16. Germany COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 17. France COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 19. Italy COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 20. Russia COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia COVID-19 RNA Vaccine Revenue Market Share, 2016-2027
Figure 24. China COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 25. Japan COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 28. India COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America COVID-19 RNA Vaccine Revenue Market Share, 2016-2027
Figure 30. Brazil COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa COVID-19 RNA Vaccine Revenue Market Share, 2016-2027
Figure 33. Turkey COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 34. Israel COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 36. UAE COVID-19 RNA Vaccine Revenue, (US$, Mn), 2016-2027
Figure 37. MODERNA COVID-19 RNA Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. CureVac COVID-19 RNA Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Zydus Cadila COVID-19 RNA Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. BioNTech COVID-19 RNA Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications